Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.

Clinical trial NCT05631626 · COMPLETED

Trial details

NCT number: NCT05631626
Sponsor: Cingulate Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

ADHD ADHD - Combined Type Attention Deficit Hyperactivity Disorder Combined Attention Deficit Hyperactivity Disorder

Start date: 2022-12-29
Primary completion: 2023-06-13
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.